We are live on ! Find out more
AF

Avanza Fonder Portfolio holdings

AUM $4.59B
1-Year Est. Return 41.03%
This Fund
S&P 500
This Quarter Est. Return
-3.95%
1 Year Est. Return
+41.03%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.61B
AUM Growth
-$328M
Cap. Flow
-$92.4M
Cap. Flow %
-2.56%
Top 10 Hldgs %
37.37%
Holding
513
New
16
Increased
123
Reduced
150
Closed
29

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$2.09M
2
CCEP icon
Coca-Cola Europacific Partners
CCEP
+$2.03M
3
HD icon
Home Depot
HD
+$1.82M
4
LRCX icon
Lam Research
LRCX
+$1.72M
5
AMAT icon
Applied Materials
AMAT
+$1.62M

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$35.4M
2
MSFT icon
Microsoft
MSFT
+$13.5M
3
NVDA icon
NVIDIA
NVDA
+$13.3M
4
AVGO icon
Broadcom
AVGO
+$7.09M
5
AMZN icon
Amazon
AMZN
+$5.26M

Sector Composition

Rank Sector Weight
1 Technology 32.67%
2 Financials 13.22%
3 Consumer Discretionary 11.84%
4 Communication Services 11.62%
5 Healthcare 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
POWL icon
476
Powell Industries
POWL
$7.58B
$50.3K ﹤0.01%
279
– –
CNM icon
477
Core & Main
CNM
$8.62B
$49.4K ﹤0.01%
999
– –
WLDN icon
478
Willdan Group
WLDN
$1.13B
$43K ﹤0.01%
562
– –
MCHP icon
479
Microchip Technology
MCHP
$42.6B
$38K ﹤0.01%
588
-9,468
-94% -$681K
CARR icon
480
Carrier Global
CARR
$53.8B
$36.8K ﹤0.01%
653
– –
HCAT icon
481
Health Catalyst
HCAT
$166M
$33.1K ﹤0.01%
26,050
– –
MGA icon
482
Magna International
MGA
$18.4B
$26.2K ﹤0.01%
337
– –
ARQ icon
483
Arq
ARQ
$90.1M
$19.6K ﹤0.01%
7,667
-5,752
-43% -$18.4K
TROW icon
484
T. Rowe Price
TROW
$24.2B
$19.6K ﹤0.01%
217
+101
+87% +$9.79K
ABVX
485
Abivax
ABVX
$11.1B
– –
-1,249
Closed -$168K
ACLX
486
DELISTED
Arcellx
ACLX
– –
-2,003
Closed -$131K
ALKS icon
487
Alkermes
ALKS
$8.13B
– –
-7,327
Closed -$205K
AUTL
488
Autolus Therapeutics
AUTL
$514M
– –
-53,522
Closed -$107K
BBIO icon
489
BridgeBio Pharma
BBIO
$16.1B
– –
-4,168
Closed -$319K
BRK.B icon
490
Berkshire Hathaway Class B
BRK.B
$1.13T
– –
-70,361
Closed -$35.4M
CELC icon
491
Celcuity
CELC
$4.52B
– –
-1,532
Closed -$153K
CMPX icon
492
Compass Therapeutics
CMPX
$346M
– –
-27,347
Closed -$147K
CRBP icon
493
Corbus Pharmaceuticals
CRBP
$179M
– –
-4,868
Closed -$39.6K
CSX icon
494
CSX Corp
CSX
$94.6B
– –
-49,284
Closed -$1.79M
ECL icon
495
Ecolab
ECL
$79.4B
– –
-3,266
Closed -$857K
IDYA icon
496
IDEAYA Biosciences
IDYA
$3.5B
– –
-4,344
Closed -$150K
IONS icon
497
Ionis Pharmaceuticals
IONS
$9.08B
– –
-3,596
Closed -$284K
IRON icon
498
Disc Medicine
IRON
$3B
– –
-1,903
Closed -$151K
IRTC icon
499
iRhythm Holdings
IRTC
$4.05B
– –
-1,264
Closed -$224K
KRYS icon
500
Krystal Biotech
KRYS
$9.56B
– –
-996
Closed -$246K
17 18 19
20
21

Similar funds

SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
SCM
Shelton Capital Management Denver, Colorado $4.57B AUM 32.26% 1-Year Est. Return
DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Avanza Fonder's Q1 2026 Portfolio in Review

As of Q1 2026, Avanza Fonder held 513 positions worth $3.61B, down 8.3% from $3.94B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Avanza Fonder's Q1 2026 filing shows 16 new, 123 increased, 150 reduced and 29 closed positions. Its largest new stake was Nutrien: 7,208 shares worth $757K. The largest sale was Berkshire Hathaway Class B, an estimated $35.4M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Avanza Fonder's largest Q1 2026 buy was Nutrien: 7,208 shares worth $757K.
  • Avanza Fonder added most to Procter & Gamble in Q1 2026, an estimated $2.09M increase.
  • Avanza Fonder's biggest Q1 2026 reduction was Microsoft, cutting an estimated $13.5M.
  • Avanza Fonder fully exited Berkshire Hathaway Class B in Q1 2026, selling an estimated $35.4M.
  • Avanza Fonder's ten largest holdings make up 37% of its $3.61B portfolio in Q1 2026.
  • Avanza Fonder opened 16 new positions and closed 29 in Q1 2026.
  • Avanza Fonder's portfolio value fell 8.3% quarter-over-quarter to $3.61B.

Based on Avanza Fonder's 13F filing for Q1 2026, filed 15 Apr 2026.